Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

ClinicalTrials.gov ID: NCT01932970

Public ClinicalTrials.gov record NCT01932970. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Multiple-dose, Single-arm Study to Switch Hemodialysis Subjects With Secondary Hyperparathyroidism From Oral Cinacalcet HCl to Intravenous AMG 416

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, multiple-dose, single-arm, open-label study to assess the impact on serum corrected calcium levels when switching patients from cinacalcet to etelcalcetide (AMG 416).

Study identification

NCT ID
NCT01932970
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
158 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 12, 2013 (Actual)
Primary completion
Jan 14, 2014 (Actual)
Completion
Feb 14, 2017 (Actual)
Last update posted
Oct 17, 2018

2013 – 2017

United States locations

U.S. sites
40
U.S. states
18
U.S. cities
40
Facility City State ZIP Site status
Research Site Alhambra California 91801 —
Research Site Azusa California 91702 —
Research Site Bakersfield California 93308 —
Research Site Chula Vista California 91910 —
Research Site La Mesa California 91942 —
Research Site Los Angeles California 90022 —
Research Site Lynwood California 90262 —
Research Site Riverside California 92505 —
Research Site Whittier California 90603 —
Research Site Arvada Colorado 80002 —
Research Site North Haven Connecticut 06473 —
Research Site Coral Springs Florida 33071 —
Research Site Hollywood Florida 33021 —
Research Site Miami Florida 33150 —
Research Site Pembroke Pines Florida 33028 —
Research Site Pinecrest Florida 33156 —
Research Site Tampa Florida 33614 —
Research Site Augusta Georgia 30909 —
Research Site Evergreen Park Illinois 60805 —
Research Site Michigan City Indiana 46360 —
Research Site Baton Rouge Louisiana 70808 —
Research Site Lafayette Louisiana 70506 —
Research Site Columbus Mississippi 39705 —
Research Site Gulfport Mississippi 39501 —
Research Site Farmington Missouri 63640 —
Research Site Kansas City Missouri 64111 —
Research Site St Louis Missouri 63136 —
Research Site Portsmouth New Hampshire 03801 —
Research Site Eatontown New Jersey 07724 —
Research Site College Point New York 11356 —
Research Site Oklahoma City Oklahoma 73116 —
Research Site Philadelphia Pennsylvania 19106 —
Research Site Orangeburg South Carolina 29118 —
Research Site Arlington Texas 76015 —
Research Site Greenville Texas 75402 —
Research Site Houston Texas 77004 —
Research Site McAllen Texas 78503 —
Research Site San Antonio Texas 78229 —
Research Site Fairfax Virginia 22033 —
Research Site Hampton Virginia 23666 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01932970, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 17, 2018 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01932970 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →